[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342568-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342568-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","otud4-promotes-the-progression-of-glioblastoma-by-deubiquitinating-cdk1-and-activating-mapk-signaling-pathway","OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway","","Glioblastoma (GBM, IDH-wild type, CNS WHO grade 4) is highly aggressive with limited treatment options and poor outcomes. The study identifies OTU deubiquitinase 4 (OTUD4) as a prognostic factor, showing that high OTUD4 expression correlates with worse survival. OTUD4 promotes GBM proliferation and invasion in vitro and in vivo by engaging CDK1 and FGFR1 to reduce their polyubiquitination, thereby stabilizing CDK1 and activating the MAPK pathway. Results support OTUD4 as a prospective therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/otud4-promotes-the-progression-of-glioblastoma-by-deubiquitinating-cdk1-and-activating-mapk-signaling-pathway/342568/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/otud4-promotes-the-progression-of-glioblastoma-by-deubiquitinating-cdk1-and-activating-mapk-signaling-pathway/342568.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does OTUD4 play in glioblastoma progression?","Question",{"text":63,"@type":64},"High OTUD4 expression is associated with poor prognosis. The study provides evidence that OTUD4 promotes GBM cell proliferation and invasion.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does OTUD4 mechanistically affect CDK1?",{"text":68,"@type":64},"OTUD4 directly interacts with CDK1 and stabilizes it by removing K11, K29, and K33-linked polyubiquitination. It also indirectly stabilizes CDK1 by deubiquitinating FGFR1.",{"name":70,"@type":61,"acceptedAnswer":71},"What signaling pathway is activated downstream of the OTUD4-CDK1 axis?",{"text":72,"@type":64},"Stabilization of CDK1 ultimately influences activation of the downstream MAPK signaling pathway via the OTUD4-CDK1-MAPK axis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342568,1790939919,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nOTUD4 promotes the progression of glioblastoma by  \ndeubiquitinating CDK1 and activating MAPK signaling pathway  \nMingxin Ci 1,2, Gaichao Zhao1,2, Chongyang Li1,2, Ruochen Liu1,2, Xiaosong Hu 1,2, Jun Pan1,2, Yang Shen 1,2, Guanghui Zhang 1,2, Yongsen Li 1,2, Li Zhang 3 ✉, Ping Liang4 ✉ and Hongjuan Cui 1,2 ✉  \n© The Author(s) 2024  \n\n|  | Glioblastoma, IDH-Wild type (GBM, CNS WHO Grade 4) is a highly heterogeneous and aggressive primary malignant brain tumor with high morbidity, high mortality, and poor patient prognosis. The global burden of GBM is increasing notably due to limited treatment options, drug delivery problems, and the lack of characteristic molecular targets. OTU deubiquitinase 4 (OTUD4) is a potential predictive factor for several cancers such as breast cancer, liver cancer, and lung cancer. However, its function in GBM remains unknown. In this study, we found that high expression of OTUD4 is positively associated with poor prognosis in GBM patients. Moreover, we provided in vitro and in vivo evidence that OTUD4 promotes the proliferation and invasion of GBM cells. Mechanism studies showed that, on the one hand, OTUD4 directly interacts with cyclin-dependent kinase 1 (CDK1) and stabilizes CDK1 by removing its K11, K29, and K33-linked polyubiquitination. On the other hand, OTUD4 binds to ﬁbroblast growth factor receptor 1 (FGFR1) and reduces FGFR1’s K6 and K27-linked polyubiquitination, thereby indirectly stabilizing CDK1, ultimately inﬂuencing the activation of the downstream MAPK signaling pathway. Collectively, our results revealed that OTUD4 promotes GBM |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| progression via OTUD4-CDK1-MAPK axis, and may be a prospective therapeutic target for GBM treatment. |  |  |\n|  | Cell Death and Disease (2024)15:179; [https://doi.org/10.1038/s41419-024-06569-x](https://doi.org/10.1038/s41419-024-06569-x) |  |\n|  |  |  |\n\nINTRODUCTION  \nGlioblastoma, IDH-Wild type(GBM, CNS WHO Grade 4 [1–3]) is a highly heterogeneous and aggressive primary malignant brain tumor with a median survival of 14 months [4, 5] . Despite improved surgical strategies and vigorous radiation and chemotherapy [6], the prognosis for GBM patients is poor [7] . It is urgent to ﬁnd new drug targets for the treatment of GBM.  \nOTU deubiquitinase 4 (OTUD4) is a deubiquitinase that belongs to the Ovarian tumor-associated proteases domain-containing proteins (OTUDs) family. Research conﬁrmed that OTUD4 is a potential predictor of several human cancers [8] and is also involved in DNA alkylation damage repair, which is important in cancer radiation and chemotherapy [9, 10] . However, the biological function of OTUD4 in GBM has not been elucidated.  \nHere, we report that OTUD4 is signiﬁcantly overexpressed in glioblastoma and is important for cell proliferation, invasion, and clonogenic capacity. Mechanistically, on the one hand, we demonstrated a direct protein interaction between OTUD4 (181-300aa) and CDK1, and OTUD4 regulates the stability of CDK1 by deubiquitination. OTUD4, on the other hand, indirectly stabilizes CDK1 by binding to and deubiquitinating FGFR1, which then positively affects the MAPK pathway. In conclusion, our ﬁndings demonstrated that the OTUD4-CDK1-MAPK axis is critical for promoting GBM progression. Our study, therefore, may offer insights for ﬁnding novel, feasible glioblastoma targets and new anticancer therapies.  \nMATERIALS AND METHODS Cell culture  \nHuman glioblastoma cell lines (A172, LN229, U87MG, and U118MG), human astroglia cells SVGP12, and human embryonic kidney (HEK) 293FT cells were originally obtained from American Type Culture Collection (ATCC, Beijing, China) . All cell lines were tested mycoplasmanegative [11] . Cell lines were cultured in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) (Gibco: Grand Island, NY, USA) supplemented wit","cbCaii8JF5FZq8q3","https://ap.wps.com/l/cbCaii8JF5FZq8q3","pdf",5572920,11,"English","# Introduction\n# Materials and Methods\n## Cell culture\n## Reagents and antibodies\n## Plasmids, transfection, and infection","[{\"question\":\"What role does OTUD4 play in glioblastoma progression?\",\"answer\":\"High OTUD4 expression is associated with poor prognosis. The study provides evidence that OTUD4 promotes GBM cell proliferation and invasion.\"},{\"question\":\"How does OTUD4 mechanistically affect CDK1?\",\"answer\":\"OTUD4 directly interacts with CDK1 and stabilizes it by removing K11, K29, and K33-linked polyubiquitination. It also indirectly stabilizes CDK1 by deubiquitinating FGFR1.\"},{\"question\":\"What signaling pathway is activated downstream of the OTUD4-CDK1 axis?\",\"answer\":\"Stabilization of CDK1 ultimately influences activation of the downstream MAPK signaling pathway via the OTUD4-CDK1-MAPK axis.\"}]","OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway | PDF",1790047185,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92ebe3db266702a1eac8724abaa2db8f.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c79d54cb9a8a40d73110845eda80f7f1.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bfaccea9e6e89f89a209a57279d2208.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13d27c1ba567975fd87d2b0747ec458d.webp",980,1301]